# Introduction of Eurartesim® in Burkina Faso, Mozambique, Ghana and Tanzania

> **NCT02199951** · — · UNKNOWN · sponsor: **INDEPTH Network** · enrollment: 10000 (estimated)

## Conditions studied

- Malaria

## Interventions

- **DRUG:** Dihydroartemisinin and piperaquine

## Key facts

- **NCT ID:** NCT02199951
- **Lead sponsor:** INDEPTH Network
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-09
- **Primary completion:** 2014-08
- **Final completion:** 2014-12
- **Target enrollment:** 10000 (ESTIMATED)
- **Last updated:** 2014-07-25

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02199951

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02199951, "Introduction of Eurartesim® in Burkina Faso, Mozambique, Ghana and Tanzania". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02199951. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*